Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Purpose</h3><p>Deuterium metabolic imaging (DMI) maps the uptake of deuterated precursors and their conversion into lactate and other markers of tumor metabolism. Even after leveraging <sup>2</sup>H's short T<sub>1</sub>s, DMI's signal-to-noise ratio (SNR) is limited. We hypothesize that a multi-echo balanced steady-state free precession (ME-bSSFP) approach would increase SNR compared to chemical shift imaging (CSI), while achieving spectral isolation of the metabolic precursors and products. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Suitably tuned <sup>2</sup>H ME-bSSFP (five echo times [TEs], ΔTE = 2.2 ms, repetition time [TR]/flip-angle = 12 ms/60°) was implemented at 15.2T and compared to CSI (TR/flip-angle = 95 ms/90°) regarding SNR and spectral isolation, in simulations, in deuterated phantoms and for the in vivo diagnosis of a mouse tumor model of pancreatic adenocarcinoma (N = 10). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Simulations predicted an SNR increase vs. CSI of 3-5, and that the peaks of <sup>2</sup>H-water, <sup>2</sup>H<sub>6,6'</sub>-glucose, and <sup>2</sup>H<sub>3,3'</sub>-lactate can be well isolated by ME-bSSFP; phantoms confirmed this. In vivo, at equal spatial resolution (1.25 × 1.25 mm<sup>2</sup>) and scan time (10 min), <sup>2</sup>H<sub>6,6'</sub>-glucose's and <sup>2</sup>H<sub>3,3'</sub>-lactate's SNR were indeed higher for bSSFP than for CSI, three-fold for glucose (57 ± 30 vs. 19 ± 11, <i>P</i> < .001), doubled for water (13 ± 5 vs. 7 ± 3, <i>P</i> = .005). The time courses and overall localization of all metabolites agreed well, comparing CSI against ME-bSSFP. However, a clearer localization of glucose in kidneys and bladder, the detection of glucose-avid rims in certain tumors, and a heterogeneous pattern of intra-tumor lactate production could only be observed using ME-bSSFP's higher resolution. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>ME-bSSFP provides greater SNR per unit time than CSI, providing for higher spatial resolution mapping of glucose uptake and lactate production in tumors.</p></section>

Improved Detection of Target Metabolites in Brain Tumors with Intermediate TE, High SNR, and High Bandwidth Spin-Echo Sequence at 5T

Three-dimensional Simultaneous Brain Mapping of T1, T2, T2*and Magnetic Susceptibility with MR Multitasking

Combining Amide Proton Transfer-Weighted and Arterial Spin Labeling Imaging to Differentiate Solitary Brain Metastases from Glioblastomas

Quantitative assessment of amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging with extrapolated semi-solid magnetization transfer reference (EMR) signals: Application to a rat glioma model at 4.7 tesla.

(1)H spectroscopic imaging of human brain at 3 Tesla: comparison of fast three-dimensional magnetic resonance spectroscopic imaging techniques

Optimization of 1H‐MRS methods for large‐volume acquisition of low‐concentration downfield resonances at 3 T and 7 T

Noninvasive Delineation of Glioma Infiltration with Combined 7T Chemical Exchange Saturation Transfer Imaging and MR Spectroscopy: A Diagnostic Accuracy Study

Influences of Experimental Parameters on Chemical Exchange Saturation Transfer (CEST) Metrics of Brain Tumors Using Animal Models at 4.7T

Insight into the Quantitative Metrics of Chemical Exchange Saturation Transfer (CEST) Imaging

[Possibilities in the differential diagnosis of brain neoplasms using the long and short time sequences of proton magnetic resonance spectroscopy].

Convex-Envelope Based Automated Quantitative Approach to Multi-Voxel 1H-MRS Applied to Brain Tumor Analysis.

In Vivo Hydrogen-1 Magnetic Resonance Spectroscopy Study of Human Intracranial Tumors.

High‐resolution 1H‐MRSI at 9.4 T by integrating relaxation enhancement and subspace imaging

Relationship between multi-pool model-based chemical exchange saturation transfer imaging, intravoxel incoherent motion MRI, and 11C-methionine uptake on PET/CT in patients with gliomas

Improving deuterium metabolic imaging (DMI) signal‐to‐noise ratio by spectroscopic multi‐echo bSSFP: A pancreatic cancer investigation

Absolute Metabolite Quantification in Individuals with Glioma and Healthy Individuals Using Whole-Brain Three-dimensional MR Spectroscopic and Echo-planar Time-resolved Imaging

Combined 7T CEST/MRS Imaging to Predict Tumor Metabolism in Glioma

Amid proton transfer (APT) and magnetization transfer (MT) MRI contrasts provide complimentary assessment of brain tumors similarly to proton magnetic resonance spectroscopy imaging (MRSI)

Nimg-56. Magnetic Resonance Spectroscopy In The Post-Treatment Metabolic Characterization Of Brain Tumors Of Glial Origin Of Central Nervous System

Quantitative Assessment of the Effects of Water Proton Concentration and Water T-1 Changes on Amide Proton Transfer (apt) and Nuclear Overhauser Enhancement (noe) Mri: the Origin of the Apt Imaging Signal in Brain Tumor

Compressed sensing for high-resolution nonlipid suppressed 1 H FID MRSI of the human brain at 9.4T